BAYER AKTIENGESELLSCHAFT desde 14/10/2019 hasta 14/10/2019 14/10/2019 16:09 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Not intended for U.S. and UK Media - U.S. FDA approves rivaroxaban to help prevent blood clots in acutely ill medical patients Número de registro: 282563